Enrique Poradosu

Companies

• Nuvectis Pharma, Inc.Chief Science & Business Off Feb 8, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• NPNuvectis Pharma, Inc. NVCT1,806,319 shares²$33.7M at $18.67Jan 6, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Jan 6, 2026Granted 150,000 shares of Nuvectis Pharma, Inc.²
• Jan 2, 2025Granted 150,000 shares of Nuvectis Pharma, Inc.³
• Nov 19, 2024Bought 2,000 shares at $4.99 of Nuvectis Pharma, Inc.⁴
• May 10, 2024Bought 500 shares at $6.29 of Nuvectis Pharma, Inc.⁵
• Jan 3, 2024Granted 130,000 shares of Nuvectis Pharma, Inc.⁶
• Mar 27, 2023Bought 500 shares at $11.55 of Nuvectis Pharma, Inc.⁷
• Jan 12, 2023Granted 115,000 shares of Nuvectis Pharma, Inc.⁸
• May 12, 2022Bought 300 shares at $16.04 of Nuvectis Pharma, Inc.⁹
• May 12, 2022Bought 370 shares at $14.76 of Nuvectis Pharma, Inc.⁹
• Apr 1, 2022Granted 60,000 shares of Nuvectis Pharma, Inc.¹⁰
• Feb 7, 2022Bought 800 shares at $3.88 of Nuvectis Pharma, Inc.¹¹
• Feb 4, 2022Bought 3,800 shares at $3.35 of Nuvectis Pharma, Inc.¹¹